ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 573,71
-0,77%
Dow Jones
40 211,72
0,00%
DAX
18 488,91
-0,60%
Brent Oil
82,905
-1,70%
Bitcoin
63 776,91
-1,66%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Portola Pharmaceuticals Inc (PTLA)

  7. Portola Pharmaceuticals Inc (PTLA) Actualités

PTLA

Portola Pharmaceuticals (PTLA)

Portola Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PTLA
DateHeureSourceTitreSymboleSociété
31/10/201613h00GlobeNewswire Inc.Portola Pharmaceuticals to Announce Third Quarter 2016 Financial Results and Host Conference Call on Monday, November 7NASDAQ:PTLAPortola Pharmaceuticals Inc
25/10/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Submits New Drug Application to U.S. FDA for Betrixaban for Extended Duration Prophylaxis of Venous T...NASDAQ:PTLAPortola Pharmaceuticals Inc
14/10/201600h07GlobeNewswire Inc.Portola Pharmaceuticals Supports “World Thrombosis Day” Campaign to Increase Awareness of Risks of Blood ClotsNASDAQ:PTLAPortola Pharmaceuticals Inc
13/09/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Upcoming Data Presentations on AndexXa™ (andexanet alfa) at Neurocritical Care Society 2...NASDAQ:PTLAPortola Pharmaceuticals Inc
12/09/201617h02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PTLAPortola Pharmaceuticals Inc
30/08/201610h01GlobeNewswire Inc.Portola Pharmaceuticals Announces Interim Results from Ongoing Phase 3b/4 ANNEXXA-4™ Study of Factor Xa Inhibitor Antidote ...NASDAQ:PTLAPortola Pharmaceuticals Inc
26/08/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Presentation of Interim Results from Phase 3b/4 ANNEXA™-4 Study of AndexXa™ (andexanet ...NASDAQ:PTLAPortola Pharmaceuticals Inc
19/08/201623h32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTLAPortola Pharmaceuticals Inc
19/08/201614h30GlobeNewswire Inc.Portola Pharmaceuticals Announces Validation of Marketing Authorization Application (MAA) by European Medicines Agency (EMA) ...NASDAQ:PTLAPortola Pharmaceuticals Inc
18/08/201604h57GlobeNewswire Inc.Portola Pharmaceuticals Receives Complete Response Letter from FDA for Biologics License Application for AndexXa™ (andexane...NASDAQ:PTLAPortola Pharmaceuticals Inc
09/08/201622h42Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTLAPortola Pharmaceuticals Inc
09/08/201622h05GlobeNewswire Inc.Portola Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
02/08/201622h05GlobeNewswire Inc.Portola Pharmaceuticals to Announce Second Quarter 2016 Financial Results and Host Conference Call on Tuesday, August 9NASDAQ:PTLAPortola Pharmaceuticals Inc
22/06/201614h20PR Newswire (US)Biotechnology Stocks in Motion -- Minerva Neurosciences, Portola Pharma, Trevena, and Anthera PharmaNASDAQ:PTLAPortola Pharmaceuticals Inc
21/06/201623h18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTLAPortola Pharmaceuticals Inc
14/06/201612h05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PTLAPortola Pharmaceuticals Inc
01/06/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Dosing of First Patient in Phase 2a Study of Cerdulatinib for Treatment of Hematologic Canc...NASDAQ:PTLAPortola Pharmaceuticals Inc
31/05/201622h05GlobeNewswire Inc.Portola Pharmaceuticals to Present at Goldman Sachs 37th Annual Global Healthcare ConferenceNASDAQ:PTLAPortola Pharmaceuticals Inc
27/05/201614h45GlobeNewswire Inc.Portola Pharmaceuticals Announces Full Results of Phase 3 APEX Study of Betrixaban Presented at International Society on Thro...NASDAQ:PTLAPortola Pharmaceuticals Inc
24/05/201618h23Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:PTLAPortola Pharmaceuticals Inc
23/05/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Upcoming Data Presentations on Betrixaban and AndexXa™ (andexanet alfa) at International ...NASDAQ:PTLAPortola Pharmaceuticals Inc
19/05/201614h35PR Newswire (US)How are Investors Treating These Biotech? - Portola Pharma, Vitae Pharma, Anthera Pharma, and Intra-Cellular TherapiesNASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/201622h05GlobeNewswire Inc.Portola Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
29/04/201622h40Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PTLAPortola Pharmaceuticals Inc
28/04/201614h00GlobeNewswire Inc.Portola Pharmaceuticals to Announce First Quarter 2016 Financial Results and Host Conference Call on Thursday, May 5NASDAQ:PTLAPortola Pharmaceuticals Inc
14/04/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Upcoming Cerdulatinib Data Presentation at American Association for Cancer Research (AACR) ...NASDAQ:PTLAPortola Pharmaceuticals Inc
11/04/201617h57Edgar (US Regulatory)Schedule 13gNASDAQ:PTLAPortola Pharmaceuticals Inc
06/04/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Presentation of Phase 3 APEX Study Results at International Society on Thrombosis and Haemo...NASDAQ:PTLAPortola Pharmaceuticals Inc
04/04/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Enters Into Clinical Collaboration Agreement with Daiichi Sankyo to Develop Andexanet Alfa with Edoxa...NASDAQ:PTLAPortola Pharmaceuticals Inc
30/03/201617h50Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PTLAPortola Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PTLA

Dernières Valeurs Consultées

BIT
FK2V2L
Vontobel
BIT
JAGE
Exchange Traded Fund Jpm...
LSE
SDHY
Ishs $ Sd Hy
NYSE
XIN
Xinyuan Real Estate
NYSE
NLS
Nautilus
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés